Inflammation reshapes how microglial cannabinoid receptors signal

Quantifying Heteromer Partitioning Reveals Inflammation-Dependent Redistribution of Microglial Adenosine A2A and Cannabinoid CB2 Receptors.

Glia β€’ β€’ Highly Relevant
πŸ€–

AI Summary

This laboratory study examined how adenosine A2A and cannabinoid CB2 receptors are organized in primary microglia, immune cells involved in brain inflammation. Using proximity ligation assay and MolBoolean analysis, the researchers found that resting microglia contain both A2A–CB2 receptor complexes and receptors that are not detected in those complexes. Activating either receptor shifted more of the detectable receptor-associated signal toward the heteromeric, or paired, state.

Inflammatory activation produced a much stronger change in receptor organization: approximately 70% of the detectable receptor-associated signal was linked to A2A–CB2 complexes. Under these inflammatory conditions, additional drug-induced redistribution was strongly limited. The findings do not show how cannabis affects people or establish a treatment benefit, but they suggest that inflammation may alter how microglial CB2 receptors respond to cannabinoid-related drugs. Future studies of CB2 pharmacology and neuroinflammation may therefore need to account for the receptor’s cellular context.

πŸ’‘ Key Findings

1
Resting microglia contain both A2A–CB2 heteromers and a substantial fraction of receptor-associated signal outside those complexes.
Good
60%
2
Activating either receptor promotes redistribution toward A2A–CB2 heteromeric complexes in microglia and in receptor-expressing HEK-293T cells.
Good
60%
3
Pro-inflammatory activation increases the proportion of detectable receptor-associated signal in heteromers to approximately 70%.
Good
65%
4
During inflammation, further agonist-induced receptor redistribution is strongly limited, indicating that inflammatory state can constrain receptor reorganization.
Good
65%

πŸ“„ Original Abstract

G protein-coupled receptor (GPCR) heteromerization represents a key organizational mechanism in cell signaling, but it remains difficult to determine, in native cells, how receptor-associated signals are distributed between non-interacting and heteromer-associated states. Here, we address this limitation by combining proximity ligation assay (PLA) with the newly applied MolBoolean methodology, enabling in situ quantification of the partitioning of adenosine A2A and cannabinoid CB2 receptor-associated signals between non-interacting fractions and A2A-CB2 heteromeric complexes in primary microglia. We show that resting microglia contain detectable A2A-CB2 heteromers together with a substantial non-interacting A2A-associated signal fraction. Selective activation of either receptor promotes redistribution of the detectable receptor-associated signal toward the heteromer-associated fraction. Ligand-induced redistribution also occurred in HEK-293T cells expressing the two receptors. In contrast, pro-inflammatory activation of primary microglia with LPS/IFN-γ markedly changes the basal organization of the receptor system, increasing the proportion of MolBoolean-detectable signal associated with A2A-CB2 complexes, with approximately 70% of the detectable receptor-associated signal corresponding to heteromeric complexes. In this inflammatory context, further agonist-induced repartitioning is strongly limited compared with that observed in resting microglia. These findings identify inflammation-dependent receptor partitioning as a quantitatively measurable feature of microglial A2A and CB2 receptor organization and provide a framework for interpreting how receptor context may influence future studies of A2A-CB2 pharmacology under neuroinflammatory conditions.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.